Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
AstraZeneca
Federal Trade Commission
Teva
Boehringer Ingelheim
Chinese Patent Office
Johnson and Johnson
Deloitte
Dow
Colorcon

Generated: August 22, 2017

DrugPatentWatch Database Preview

ARGATROBAN Drug Profile

« Back to Dashboard

Which patents cover Argatroban, and when can generic versions of Argatroban launch?

Argatroban is a drug marketed by Fresenius Kabi Usa, Hospira Inc, Mylan Institutional, Hikma Pharm Co Ltd, Par Sterile Products, Novartis Pharms Corp, Teva Pharms Usa, Sandoz, Eagle Pharms, and Gland Pharma Ltd. and is included in eleven NDAs. There are two patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in ARGATROBAN is argatroban. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the argatroban profile page.

Summary for Tradename: ARGATROBAN

Patents:0
Applicants:10
NDAs:11
Suppliers / Packagers: see list5
Bulk Api Vendors: see list92
Clinical Trials: see list19
Patent Applications: see list3,748
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ARGATROBAN at DailyMed

Pharmacology for Tradename: ARGATROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
ARGATROBAN
argatroban
INJECTABLE;INJECTION201811-001Mar 23, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
ARGATROBAN
argatroban
INJECTABLE;INJECTION020883-001Jun 30, 2000APRXYesYes► Subscribe► Subscribe► Subscribe
Hikma Pharm Co Ltd
ARGATROBAN
argatroban
INJECTABLE;INJECTION203049-002Sep 30, 2016RXYesYes► Subscribe► Subscribe► Subscribe
Gland Pharma Ltd
ARGATROBAN IN SODIUM CHLORIDE
argatroban
INJECTABLE;IV (INFUSION)205570-001May 22, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ARGATROBAN IN 0.9% SODIUM CHLORIDE
argatroban
INJECTABLE;IV (INFUSION)206769-001Dec 15, 2014RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ARGATROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
ARGATROBAN
argatroban
INJECTABLE;INJECTION020883-001Jun 30, 2000► Subscribe► Subscribe
Novartis Pharms Corp
ARGATROBAN
argatroban
INJECTABLE;INJECTION020883-001Jun 30, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ARGATROBAN

Drugname Dosage Strength RLD Submissiondate
argatroban in sodium chlorideInjection1 mg/mL, 50 mL vialsArgatroban12/16/2011
argatrobanInjection100 mg/mL, 2.5 mL vialsArgatroban9/24/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Cantor Fitzgerald
McKinsey
Baxter
Fish and Richardson
Boehringer Ingelheim
Chinese Patent Office
Federal Trade Commission
Mallinckrodt
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot